carmustine with propylene glycol formulation vi-0609
Generic: Carmustine with Propylene Glycol Formulation VI-0609
carmustine with propylene glycol formulation vi-0609: 1 clinical trial tracked.
carmustine with propylene glycol formulation vi-0609 evidence translation
What we can confirm
1 tracked trial
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about carmustine with propylene glycol formulation vi-0609, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trials (1)
A Randomized Phase 2 Study of Carmustine Formulated With and Without Ethanol as Part of BEAM Chemotherapy Conditioning for Subjects With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (AHCT)
Primary endpoint: Evaluation of infusion-related toxicities
InterventionalRandomizedopen49 targetStarted 2025-03Completion 2027-044 sites · United StatesVIVUS LLC